STOCKS | Novo Nordisk Sues Eli Lilly Over Alleged False Statements in Obesity Drug Ads
2026-07-21 11:35:56
According to Jin10, Novo Nordisk (NVO.N) is suing Eli Lilly (LLY.N) in U.S. federal court, accusing it of making false statements in obesity drug advertisements.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
